X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
icotinib (164) 164
gefitinib (94) 94
index medicus (79) 79
chemotherapy (76) 76
oncology (72) 72
humans (70) 70
erlotinib (68) 68
lung cancer (57) 57
mutation (55) 55
non-small cell lung cancer (48) 48
epidermal growth factor (47) 47
lung cancer, non-small cell (41) 41
cancer (40) 40
lung neoplasms - drug therapy (40) 40
tyrosine kinase inhibitor (38) 38
male (37) 37
quinazolines - therapeutic use (37) 37
egfr (36) 36
adenocarcinoma (35) 35
crown ethers - therapeutic use (35) 35
icotinib hydrochloride (34) 34
cancer therapies (33) 33
female (33) 33
epidermal growth factor receptor (32) 32
carcinoma, non-small-cell lung - drug therapy (30) 30
middle aged (30) 30
care and treatment (28) 28
efficacy (28) 28
aged (26) 26
open-label (26) 26
metastasis (25) 25
pharmacology & pharmacy (25) 25
analysis (24) 24
lung neoplasms - genetics (24) 24
genetic aspects (23) 23
lung neoplasms (23) 23
neoplasms. tumors. oncology. including cancer and carcinogens (23) 23
patients (23) 23
tyrosine kinase inhibitors (23) 23
antineoplastic agents - therapeutic use (22) 22
egfr mutation (22) 22
growth-factor receptor (22) 22
nsclc (22) 22
treatment outcome (22) 22
trial (22) 22
tyrosine (22) 22
adult (21) 21
quinazolines - pharmacology (21) 21
receptor, epidermal growth factor - genetics (21) 21
respiratory system (21) 21
1st-line treatment (20) 20
crown ethers - pharmacology (20) 20
lung neoplasms - pathology (20) 20
carcinoma, non-small-cell lung - genetics (19) 19
cell lung-cancer (19) 19
kinases (19) 19
therapy (19) 19
multicenter (18) 18
apoptosis (17) 17
medicine, research & experimental (17) 17
non-small-cell lung cancer (17) 17
tumors (17) 17
carcinoma, non-small-cell lung - pathology (16) 16
crown ethers - adverse effects (16) 16
medical prognosis (16) 16
mutations (16) 16
quinazolines - adverse effects (16) 16
respiratory tract diseases (16) 16
retrospective studies (16) 16
animals (15) 15
drug therapy (15) 15
health aspects (15) 15
lung adenocarcinoma (15) 15
original research (15) 15
survival (15) 15
biotechnology & applied microbiology (14) 14
clinical trials (14) 14
non-small cell lung carcinoma (14) 14
receptor, epidermal growth factor - antagonists & inhibitors (14) 14
safety (14) 14
antimitotic agents (13) 13
antineoplastic agents (13) 13
antineoplastic agents - pharmacology (13) 13
erbb receptors - genetics (13) 13
growth (13) 13
phase-iii (13) 13
research (13) 13
targeted therapy (13) 13
cell line, tumor (12) 12
disease-free survival (12) 12
epidermal growth factor receptors (12) 12
medical research (12) 12
oncotargets and therapy (12) 12
quinazolines - administration & dosage (12) 12
studies (12) 12
afatinib (11) 11
antineoplastic agents - adverse effects (11) 11
case report (11) 11
crown ethers - administration & dosage (11) 11
double-blind (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 02/2019, Volume 27, Issue 3, pp. 545 - 551
[Display omitted] Epidermal growth factor receptor (EGFR) has emerged as an attracting target in the field of imaging and treatment for non-small cell lung... 
Click reaction | NSCLC | PET imaging | 18F-icotinib | EGFR
Journal Article
Chinese Journal of Lung Cancer, ISSN 1009-3419, 2015, Volume 18, Issue 6, pp. 369 - 373
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 13, pp. 5521 - 5524
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. 1027 - 1030
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR‐TKIs) have become the first choice for patients with sensitive mutations and have... 
GEFITINIB | ONCOLOGY | LANDSCAPE | ICOTINIB | DRIVER | CANCER | ERLOTINIB | KINASE DOMAIN
Journal Article
by Yao, B.Q and Jia, Y and Guo, J.Q and Zhao, Q and Sun, H and Zhang, J.P
Zhonghua zhong liu za zhi [Chinese journal of oncology], ISSN 0253-3766, 08/2017, Volume 39, Issue 8, pp. 573 - 578
Journal Article
Chinese Journal of Lung Cancer, ISSN 1009-3419, 2013, Volume 16, Issue 5, pp. 240 - 245
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 01/2014, Volume 23, Issue 2, pp. 235 - 240
Journal Article
by Wu, PY and Yin, DT and Liu, JM and Zhou, HG and Guo, MY and Liu, J and Liu, Y and Wang, XB and Chen, CY
NANOSCALE, ISSN 2040-3364, 11/2019, Volume 11, Issue 41, pp. 19520 - 19528
The therapeutic efficacy of anti-cancer nanomedicines is generally constrained due to limited accumulation in the solid tumors. In this study, we developed a... 
NANOPARTICLES | PHYSICS, APPLIED | ACID | GENE DELIVERY | ICOTINIB | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | HEPATOTOXICITY | CHEMISTRY, MULTIDISCIPLINARY
Journal Article
Chinese Journal of Lung Cancer, ISSN 1009-3419, 04/2016, Volume 19, Issue 4, pp. 200 - 206
Journal Article
Annals of Oncology, ISSN 0923-7534, 2017, Volume 28, Issue 10, pp. 2443 - 2450
Journal Article
Medicine, ISSN 0025-7974, 12/2018, Volume 97, Issue 51, p. e13809
Rationale: Mutation p.A289V involving extracellular region of epidermal growth factor receptor (EGFR) exon 7 has not yet been reported in nonsmall cell lung... 
EGFR mutation | tyrosine kinase inhibitors | Icotinib | MEDICINE, GENERAL & INTERNAL | nonsmall cell lung cancer | case report | FACTOR RECEPTOR GENE
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 05/2018, Volume 27, Issue 9, pp. 973 - 977
Journal Article
Chinese Journal of Oncology, ISSN 0253-3766, 08/2012, Volume 34, Issue 8, pp. 627 - 634
Journal Article
Chinese Journal of Cancer Prevention and Treatment, ISSN 1673-5269, 03/2016, Volume 23, Issue 6, pp. 389 - 393
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 11/2015, Volume 24, Issue 21, pp. 2516 - 2520
Journal Article
Zhonghua zhong liu za zhi [Chinese journal of oncology], ISSN 0253-3766, 02/2019, Volume 41, Issue 2, pp. 152 - 153
Journal Article
Chinese Journal of Lung Cancer, ISSN 1009-3419, 12/2015, Volume 18, Issue 12, pp. 734 - 739
Journal Article
RESPIRATORY RESEARCH, ISSN 1465-993X, 10/2019, Volume 20, Issue 1, pp. 1 - 16
Background Icotinib has been widely used in patients with non-small cell lung cancer (NSCLC), and have significantly enhanced the overall survival rate of... 
Exosomal MET | LUNG-CANCER | GEFITINIB | MELANOMA | NSCLC | RESPIRATORY SYSTEM | ACQUIRED-RESISTANCE | Migration and invasion | Icotinib resistance | DRUG-RESISTANCE | INHIBITOR | Genetic aspects | Messenger RNA | Metastasis | Drug resistance | Lung cancer, Non-small cell | Analysis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.